title: Cocaine snorting may induce ocular surface damage through corneal sensitivity impairment.
abstract: OBJECTIVE
  Cocaine abuse may cause severe ischemic and necrotic tissue damage in several organs, including the eye. However, the cornea is an avascular tissue relying on sensitive nerves for its trophic support, and the pathogenesis of cocaine-induced corneal lesions is unclear. In this study, we aimed to investigate if corneal sensitivity, ocular surface, and tear function are damaged by habitual cocaine snorting.
  
  
  METHODS
  Ocular examination, corneal sensitivity, and tear function testing were carried out in 48 cocaine addicts, and in 22 heroin addicts and 30 drug-free age/sex-matched individuals who served as controls. We also performed corneal confocal microscopy, conjunctival impression cytology, and tear sample collection to evaluate corneal and conjunctival morphology, and the presence of cocaine in tears. Statistical analysis was performed to compare groups and to correlate clinical findings with anamnestic data on cocaine use.
  
  
  RESULTS
  We observed decreased corneal sensitivity in 26 cocaine addicts, and neurotrophic keratitis in six of them, with corneal damage, absence of symptoms, reduced tear production, and prolonged interblink-time. No significant changes in ocular surface parameters including corneal sensitivity were observed in heroin addicts. The major risk factors for developing cocaine-induced neurotrophic keratitis appeared to be duration and frequency of drug abuse.
  
  
  CONCLUSIONS
  A complete ophthalmic evaluation including corneal sensitivity testing should be planned for an optimal management of cocaine addicts, even in the absence of ocular symptoms, to reduce the risk of corneal lesions and consequent vision impairment. Sensory nerve damage should also be evaluated in cocaine-induced lesions of other organs.
authors: IRCCS Fondazione GB Bietti, Via Livenza, 3, 00198, Rome, Italy, f.mantelli@unicampus.it.
authors: Flavio
authors: F
authors: Mantelli
authors: Alessandro
authors: A
authors: Lambiase
authors: Marta
authors: M
authors: Sacchetti
authors: Valerio
authors: V
authors: Orlandi
authors: Alba
authors: A
authors: Rosa
authors: Pietro
authors: P
authors: Casella
authors: Stefano
authors: S
authors: Bonini
mesh_terms: D000328:Adult; D019970:Cocaine-Related Disorders / Q000150:complications*; D003315:Cornea / Q000294:innervation; D005260:Female; D006556:Heroin Dependence / Q000150:complications; D006801:Humans; D006987:Hypesthesia / Q000175:diagnosis / Q000209:etiology*; D007634:Keratitis / Q000175:diagnosis / Q000209:etiology*; D007766:Lacrimal Apparatus Diseases / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D018613:Microscopy, Confocal; D013666:Tears / Q000502:physiology; D014792:Visual Acuity
references: Eye (Lond). 2003 Nov;17(8):989-95
references: 14631406
references: Arch Ophthalmol. 1989 Jun;107(6):831-5
references: 2730401
references: Curr Med Chem. 2012;19(33):5612-8
references: 22856661
references: Expert Opin Drug Metab Toxicol. 2013 Aug;9(8):983-8
references: 23617273
references: Eur J Ophthalmol. 2011 May-Jun;21(3):251-7
references: 20853257
references: Ocul Surf. 2007 Apr;5(2):108-52
references: 17508118
references: Curr Opin Ophthalmol. 1999 Aug;10(4):270-6
references: 10621535
references: Int Ophthalmol Clin. 2001 Winter;41(1):1-11
references: 11198136
references: Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4309-15
references: 17003420
references: Am J Ophthalmol. 1989 Dec 15;108(6):732
references: 2596556
references: J Psychoactive Drugs. 2013 Apr-Jun;45(2):195-8
references: 23909007
references: Am J Med. 1994 Aug;97(2):198-9
references: 8059789
references: Expert Rev Mol Diagn. 2013 Mar;13(2):119-29
references: 23477552
references: Exp Eye Res. 2003 May;76(5):521-42
references: 12697417
references: Am J Ophthalmol. 2007 May;143(5):763-771
references: 17362862
references: J Am Optom Assoc. 1995 Nov;66(11):712-20
references: 8576537
references: Invest Ophthalmol. 1975 Apr;14(4):299-302
references: 1123285
references: Ophthalmologica. 2008;222(5):296-301
references: 18566545
references: Cornea. 2001 May;20(4):374-84
references: 11333324
references: Curr Med Chem. 2012;19(33):5624-46
references: 22934772
references: Ophthalmology. 1993 Feb;100(2):187-91
references: 8437825
references: Clin Oral Investig. 2010 Dec;14(6):621-8
references: 20063023
references: Laryngoscope. 1989 Sep;99(9):918-24
references: 2770383
references: Neuropsychopharmacology. 2008 Jul;33(8):1779-97
references: 17928814
references: Ann Ophthalmol. 1990 Jul;22(7):249-54
references: 2393222
references: Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4581-7
references: 19407012
references: Arq Bras Oftalmol. 2010 Jul-Aug;73(4):329-32
references: 20944934